Shine Investment Advisory Services’s Teva Pharmaceuticals TEVA Stock Holding History

Shine Investment Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$2K	Hold	203	–	–	﹤0.01%	690
2020 Q2	$3K	Hold	203	–	–	﹤0.01%	692
2020 Q1	$2K	Hold	203	–	–	﹤0.01%	684
2019 Q4	$2K	Buy	+203	New	+$1.81K	﹤0.01%	707
2018 Q1	–	Sell	-417	Closed	-$8K	–	671
2017 Q4	$8K	Sell	417 -1,714	-80%	-$25.8K	﹤0.01%	578
2017 Q3	$38K	Sell	2,131 -526	-20%	-$11.8K	0.02%	345
2017 Q2	$88K	Buy	+2,657	New	+$82.2K	0.04%	172

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Shine Investment Advisory Services's TEVA Position: Q3 2020 in Review

Shine Investment Advisory Services held its Teva Pharmaceuticals (TEVA) position steady in Q3 2020 at 203 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #690.

Shine Investment Advisory Services first reported a position in TEVA in Q2 2017 and has held it in 7 quarters since. The position peaked at $88K in Q2 2017. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

Shine Investment Advisory Services held 203 shares of Teva Pharmaceuticals worth $2K as of Q3 2020.
Shine Investment Advisory Services left its Teva Pharmaceuticals share count unchanged in Q3 2020.
Teva Pharmaceuticals made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #690 holding.
Shine Investment Advisory Services first reported a position in Teva Pharmaceuticals in Q2 2017 and has held it in 7 quarters since.
Shine Investment Advisory Services's Teva Pharmaceuticals position peaked at $88K in Q2 2017.
444 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.